Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-17

Clinical Trial Update: Does Staphylococcus Aureus Bacteremia Early Dual Therapy Improve Outcomes? [Phase 4]

View source ↗

Summary

This entry describes a Phase 4 clinical trial investigating early dual antimicrobial therapy for Staphylococcus aureus bacteremia, currently enrolling by invita…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: West Virginia University | Conditions: Staphylococcus Aureus Bacteremia | Phase 4 | Status: ENROLLING_BY_INVITATION